Atlanta Consulting Group Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-508	Closed	-$534K	–	201
2024 Q3	$534K	Buy	+508	New	+$534K	0.13%	126